APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibody-drug Conjugates

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

Selected research

Industry Growth & Trends

Global Antibody-drug Conjugates Industry Growth and Trends Forecast to 2032

22 December 202574 pages

Choose your research edition.

Industry ResearchAntibody-drug Conjugates Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibody-drug Conjugates Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Antibody-drug Conjugates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibody-drug Conjugates Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibody-drug Conjugates Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Antibody-drug Conjugates market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antibody-drug Conjugates market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antibody-drug Conjugates market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antibody-drug Conjugates.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antibody-drug Conjugates market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antibody-drug Conjugates Market by Company

ImmunoGen

Seattle Genetics

Roche

Takeda

Antibody-drug Conjugates Segment by Type

Adcetris

Kadcyla

Antibody-drug Conjugates Segment by Application

Breast Cancer

Lymphoma

Antibody-drug Conjugates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody-drug Conjugates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibody-drug Conjugates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody-drug Conjugates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antibody-drug Conjugates manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antibody-drug Conjugates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adcetris Table 2. Major Company of Kadcyla Table 3. Global Antibody-drug Conjugates Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 5. Global Antibody-drug Conjugates Sales Market Share in Volume by Type (2021-2026) Table 6. Global Antibody-drug Conjugates Sales by Type (2021-2026) & (US$ Million) Table 7. Global Antibody-drug Conjugates Sales Market Share in Value by Type (2021-2026) Table 8. Global Antibody-drug Conjugates Price by Type (2021-2026) & (USD/Kg) Table 9. Global Antibody-drug Conjugates Sales by Type (2027-2032) & (Kg) Table 10. Global Antibody-drug Conjugates Sales Market Share in Volume by Type (2027-2032) Table 11. Global Antibody-drug Conjugates Sales by Type (2027-2032) & (US$ Million) Table 12. Global Antibody-drug Conjugates Sales Market Share in Value by Type (2027-2032) Table 13. Global Antibody-drug Conjugates Price by Type (2027-2032) & (USD/Kg) Table 14. North America Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 15. North America Antibody-drug Conjugates Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 17. Europe Antibody-drug Conjugates Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Antibody-drug Conjugates Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 21. Latin America Antibody-drug Conjugates Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Antibody-drug Conjugates Sales by Type (2021-2026) & (US$ Million) Table 24. Antibody-drug Conjugates Industry Trends Table 25. Antibody-drug Conjugates Industry Drivers Table 26. Antibody-drug Conjugates Industry Opportunities and Challenges Table 27. Antibody-drug Conjugates Industry Restraints Table 28. Global Antibody-drug Conjugates Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Antibody-drug Conjugates Revenue Market Share by Company (2021-2026) Table 30. Global Antibody-drug Conjugates Sales by Company (2021-2026) & (Kg) Table 31. Global Antibody-drug Conjugates Sales Share by Company (2021-2026) Table 32. Global Antibody-drug Conjugates Market Price by Company (2021-2026) & (USD/Kg) Table 33. Global Antibody-drug Conjugates Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Antibody-drug Conjugates Major Company Production Sites and Headquarters Table 35. Global Antibody-drug Conjugates Company, Product Type & Application Table 36. Global Antibody-drug Conjugates Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Antibody-drug Conjugates Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Antibody-drug Conjugates Sales by Region (2021-2026) & (Kg) Table 41. Global Antibody-drug Conjugates Sales Market Share in Volume by Region (2021-2026) Table 42. Global Antibody-drug Conjugates Sales by Region (2021-2026) & (US$ Million) Table 43. Global Antibody-drug Conjugates Sales Market Share in Value by Region (2021-2026) Table 44. Global Antibody-drug Conjugates Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Global Antibody-drug Conjugates Sales by Region (2027-2032) & (Kg) Table 46. Global Antibody-drug Conjugates Sales Market Share in Volume by Region (2027-2032) Table 47. Global Antibody-drug Conjugates Sales by Region (2027-2032) & (US$ Million) Table 48. Global Antibody-drug Conjugates Sales Market Share in Value by Region (2027-2032) Table 49. Global Antibody-drug Conjugates Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 50. Global Antibody-drug Conjugates Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 52. Global Antibody-drug Conjugates Sales Market Share in Volume by Application (2021-2026) Table 53. Global Antibody-drug Conjugates Sales by Application (2021-2026) & (US$ Million) Table 54. Global Antibody-drug Conjugates Sales Market Share in Value by Application (2021-2026) Table 55. Global Antibody-drug Conjugates Price by Application (2021-2026) & (USD/Kg) Table 56. Global Antibody-drug Conjugates Sales by Application (2027-2032) & (Kg) Table 57. Global Antibody-drug Conjugates Sales Market Share in Volume by Application (2027-2032) Table 58. Global Antibody-drug Conjugates Sales by Application (2027-2032) & (US$ Million) Table 59. Global Antibody-drug Conjugates Sales Market Share in Value by Application (2027-2032) Table 60. Global Antibody-drug Conjugates Price by Application (2027-2032) & (USD/Kg) Table 61. North America Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 62. North America Antibody-drug Conjugates Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 64. Europe Antibody-drug Conjugates Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Antibody-drug Conjugates Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 68. Latin America Antibody-drug Conjugates Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Antibody-drug Conjugates Sales by Application (2021-2026) & (US$ Million) Table 71. ImmunoGen Company Information Table 72. ImmunoGen Business Overview Table 73. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. ImmunoGen Antibody-drug Conjugates Product Portfolio Table 75. ImmunoGen Recent Development Table 76. Seattle Genetics Company Information Table 77. Seattle Genetics Business Overview Table 78. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Seattle Genetics Antibody-drug Conjugates Product Portfolio Table 80. Seattle Genetics Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Roche Antibody-drug Conjugates Product Portfolio Table 85. Roche Recent Development Table 86. Takeda Company Information Table 87. Takeda Business Overview Table 88. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Takeda Antibody-drug Conjugates Product Portfolio Table 90. Takeda Recent Development Table 91. North America Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 92. North America Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 93. North America Antibody-drug Conjugates Sales Market Share by Country (2021-2026) Table 94. North America Antibody-drug Conjugates Sales Forecast by Country (2027-2032) & (Kg) Table 95. North America Antibody-drug Conjugates Sales Market Share Forecast by Country (2027-2032) Table 96. North America Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Antibody-drug Conjugates Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Antibody-drug Conjugates Market Share by Country (2021-2026) Table 99. North America Antibody-drug Conjugates Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Antibody-drug Conjugates Market Share Forecast by Country (2027-2032) Table 101. Europe Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 102. Europe Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 103. Europe Antibody-drug Conjugates Sales Market Share by Country (2021-2026) Table 104. Europe Antibody-drug Conjugates Sales Forecast by Country (2027-2032) & (Kg) Table 105. Europe Antibody-drug Conjugates Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Antibody-drug Conjugates Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Antibody-drug Conjugates Market Share by Country (2021-2026) Table 109. Europe Antibody-drug Conjugates Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Antibody-drug Conjugates Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 113. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Antibody-drug Conjugates Sales Forecast by Country (2027-2032) & (Kg) Table 115. Asia-Pacific Antibody-drug Conjugates Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Antibody-drug Conjugates Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Antibody-drug Conjugates Market Share by Country (2021-2026) Table 119. Asia-Pacific Antibody-drug Conjugates Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Antibody-drug Conjugates Market Share Forecast by Country (2027-2032) Table 121. Latin America Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 122. Latin America Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 123. Latin America Antibody-drug Conjugates Sales Market Share by Country (2021-2026) Table 124. Latin America Antibody-drug Conjugates Sales Forecast by Country (2027-2032) & (Kg) Table 125. Latin America Antibody-drug Conjugates Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Antibody-drug Conjugates Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Antibody-drug Conjugates Market Share by Country (2021-2026) Table 129. Latin America Antibody-drug Conjugates Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Antibody-drug Conjugates Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 133. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Antibody-drug Conjugates Sales Forecast by Country (2027-2032) & (Kg) Table 135. Middle East and Africa Antibody-drug Conjugates Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Antibody-drug Conjugates Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Antibody-drug Conjugates Market Share by Country (2021-2026) Table 139. Middle East and Africa Antibody-drug Conjugates Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Antibody-drug Conjugates Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Antibody-drug Conjugates Distributors List Table 144. Antibody-drug Conjugates Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Antibody-drug Conjugates Image Figure 2. Global Antibody-drug Conjugates Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibody-drug Conjugates Market Size (2021-2032) & (US$ Million) Figure 4. Global Antibody-drug Conjugates Sales (2021-2032) & (Kg) Figure 5. Adcetris Image Figure 6. Global Adcetris Sales YoY Growth (2021-2032) & (Kg) Figure 7. Kadcyla Image Figure 8. Global Kadcyla Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Antibody-drug Conjugates Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Antibody-drug Conjugates Market Share by Type 2025 VS 2032 Figure 11. North America Antibody-drug Conjugates Sales Market Share in Volume by Type in 2025 Figure 12. North America Antibody-drug Conjugates Sales Market Share in Value by Type in 2025 Figure 13. Europe Antibody-drug Conjugates Sales Market Share in Volume by Type in 2025 Figure 14. Europe Antibody-drug Conjugates Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Antibody-drug Conjugates Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Antibody-drug Conjugates Sales Market Share in Value by Type in 2025 Figure 17. Latin America Antibody-drug Conjugates Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Antibody-drug Conjugates Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Antibody-drug Conjugates Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Antibody-drug Conjugates Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Antibody-drug Conjugates Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Breast Cancer Image Figure 24. Global Breast Cancer Sales YoY Growth (2021-2032) & (Kg) Figure 25. Lymphoma Image Figure 26. Global Lymphoma Sales YoY Growth (2021-2032) & (Kg) Figure 27. Global Antibody-drug Conjugates Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Antibody-drug Conjugates Market Share by Application 2025 VS 2032 Figure 29. North America Antibody-drug Conjugates Sales Market Share in Volume by Application in 2025 Figure 30. North America Antibody-drug Conjugates Sales Market Share in Value by Application in 2025 Figure 31. Europe Antibody-drug Conjugates Sales Market Share in Volume by Application in 2025 Figure 32. Europe Antibody-drug Conjugates Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Antibody-drug Conjugates Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Antibody-drug Conjugates Sales Market Share in Value by Application in 2025 Figure 35. Latin America Antibody-drug Conjugates Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Antibody-drug Conjugates Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Antibody-drug Conjugates Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Antibody-drug Conjugates Sales Market Share in Value by Application in 2025 Figure 39. North America Antibody-drug Conjugates Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 40. North America Antibody-drug Conjugates Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Antibody-drug Conjugates Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Antibody-drug Conjugates Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Antibody-drug Conjugates Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. Europe Antibody-drug Conjugates Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antibody-drug Conjugates Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Antibody-drug Conjugates Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Antibody-drug Conjugates Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Asia-Pacific Antibody-drug Conjugates Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Antibody-drug Conjugates Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Antibody-drug Conjugates Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Antibody-drug Conjugates Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Latin America Antibody-drug Conjugates Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Antibody-drug Conjugates Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Antibody-drug Conjugates Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Antibody-drug Conjugates Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Middle East and Africa Antibody-drug Conjugates Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Antibody-drug Conjugates Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Antibody-drug Conjugates Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Antibody-drug Conjugates Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Antibody-drug Conjugates Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Adcetris
  • Kadcyla
Applications
  • Breast Cancer
  • Lymphoma
Companies covered
  • ImmunoGen
  • Seattle Genetics
  • Roche
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antibody-drug Conjugates Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antibody-drug Conjugates Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antibody-drug Conjugates Market by Type
  6. 1.3.1 Adcetris
  7. 1.3.2 Kadcyla
  8. 1.4 Global Antibody-drug Conjugates Market Size by Type
  9. 1.4.1 Global Antibody-drug Conjugates Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Antibody-drug Conjugates Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Antibody-drug Conjugates Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Antibody-drug Conjugates Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Antibody-drug Conjugates Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Antibody-drug Conjugates Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Antibody-drug Conjugates Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Antibody-drug Conjugates Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antibody-drug Conjugates Industry Trends
  2. 2.2 Antibody-drug Conjugates Industry Drivers
  3. 2.3 Antibody-drug Conjugates Industry Opportunities and Challenges
  4. 2.4 Antibody-drug Conjugates Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antibody-drug Conjugates Revenue (2021-2026)
  2. 3.2 Global Top Players by Antibody-drug Conjugates Sales (2021-2026)
  3. 3.3 Global Top Players by Antibody-drug Conjugates Price (2021-2026)
  4. 3.4 Global Antibody-drug Conjugates Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antibody-drug Conjugates Major Company Production Sites & Headquarters
  6. 3.6 Global Antibody-drug Conjugates Company, Product Type & Application
  7. 3.7 Global Antibody-drug Conjugates Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antibody-drug Conjugates Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antibody-drug Conjugates Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antibody-drug Conjugates Tier 1, Tier 2, and Tier 3
4 Antibody-drug Conjugates Regional Status and Outlook
  1. 4.1 Global Antibody-drug Conjugates Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antibody-drug Conjugates Historic Market Size by Region
  3. 4.2.1 Global Antibody-drug Conjugates Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antibody-drug Conjugates Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antibody-drug Conjugates Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antibody-drug Conjugates Forecasted Market Size by Region
  7. 4.3.1 Global Antibody-drug Conjugates Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antibody-drug Conjugates Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antibody-drug Conjugates Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antibody-drug Conjugates by Application
  1. 5.1 Antibody-drug Conjugates Market by Application
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Lymphoma
  4. 5.2 Global Antibody-drug Conjugates Market Size by Application
  5. 5.2.1 Global Antibody-drug Conjugates Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Antibody-drug Conjugates Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Antibody-drug Conjugates Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Antibody-drug Conjugates Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Antibody-drug Conjugates Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Antibody-drug Conjugates Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Antibody-drug Conjugates Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Antibody-drug Conjugates Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ImmunoGen
  2. 6.1.1 ImmunoGen Company Information
  3. 6.1.2 ImmunoGen Business Overview
  4. 6.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ImmunoGen Antibody-drug Conjugates Product Portfolio
  6. 6.1.5 ImmunoGen Recent Developments
  7. 6.2 Seattle Genetics
  8. 6.2.1 Seattle Genetics Company Information
  9. 6.2.2 Seattle Genetics Business Overview
  10. 6.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Seattle Genetics Antibody-drug Conjugates Product Portfolio
  12. 6.2.5 Seattle Genetics Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Antibody-drug Conjugates Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Takeda
  20. 6.4.1 Takeda Company Information
  21. 6.4.2 Takeda Business Overview
  22. 6.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Takeda Antibody-drug Conjugates Product Portfolio
  24. 6.4.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Antibody-drug Conjugates Sales by Country
  2. 7.1.1 North America Antibody-drug Conjugates Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antibody-drug Conjugates Sales by Country (2021-2026)
  4. 7.1.3 North America Antibody-drug Conjugates Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antibody-drug Conjugates Market Size by Country
  6. 7.2.1 North America Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antibody-drug Conjugates Market Size by Country (2021-2026)
  8. 7.2.3 North America Antibody-drug Conjugates Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antibody-drug Conjugates Sales by Country
  2. 8.1.1 Europe Antibody-drug Conjugates Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antibody-drug Conjugates Sales by Country (2021-2026)
  4. 8.1.3 Europe Antibody-drug Conjugates Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antibody-drug Conjugates Market Size by Country
  6. 8.2.1 Europe Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antibody-drug Conjugates Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antibody-drug Conjugates Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antibody-drug Conjugates Sales by Country
  2. 9.1.1 Asia-Pacific Antibody-drug Conjugates Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antibody-drug Conjugates Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antibody-drug Conjugates Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antibody-drug Conjugates Market Size by Country
  6. 9.2.1 Asia-Pacific Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antibody-drug Conjugates Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antibody-drug Conjugates Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antibody-drug Conjugates Sales by Country
  2. 10.1.1 South America Antibody-drug Conjugates Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antibody-drug Conjugates Sales by Country (2021-2026)
  4. 10.1.3 South America Antibody-drug Conjugates Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antibody-drug Conjugates Market Size by Country
  6. 10.2.1 South America Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antibody-drug Conjugates Market Size by Country (2021-2026)
  8. 10.2.3 South America Antibody-drug Conjugates Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antibody-drug Conjugates Sales by Country
  2. 11.1.1 Middle East and Africa Antibody-drug Conjugates Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antibody-drug Conjugates Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antibody-drug Conjugates Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antibody-drug Conjugates Market Size by Country
  6. 11.2.1 Middle East and Africa Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antibody-drug Conjugates Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antibody-drug Conjugates Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antibody-drug Conjugates Value Chain Analysis
  2. 12.1.1 Antibody-drug Conjugates Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antibody-drug Conjugates Production Mode & Process
  7. 12.2 Antibody-drug Conjugates Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antibody-drug Conjugates Distributors
  10. 12.2.3 Antibody-drug Conjugates Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst